Skip to main content
. 2020 Dec 5;3(2):100219. doi: 10.1016/j.jhepr.2020.100219

Fig. 3.

Fig. 3

Testing pathway for patients with a diagnosis of NAFLD in non-hepatology specialties.

An initial FIB-4 is followed by elastography or a patented serum non-invasive test such as ELF or FibroMeter. The target lesion is the presence of advanced fibrosis. NIT, non-invasive test.